Presence of high levels of MT1‐MMP protein in fibroblastic cells of human invasive carcinomas

No abstract is available for this paper.

• Publication year

  1999

• Venue

  International Journal of Cancer

• Publication date

  1999-07-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-0215(19990719)82:2<208::AID-IJC10>3.0.CO;2-9PMID 10389754
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Type IV collagenases in invasive tumors

  2005cited by this paper
• The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A

  1998influential reference
• Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) Binds to the Catalytic Domain of the Cell Surface Receptor, Membrane Type 1-Matrix Metalloproteinase 1 (MT1-MMP)*

  1998cited by this paper
• In Vivo Evidence That the Stromelysin-3 Metalloproteinase Contributes in a Paracrine Manner to Epithelial Cell Malignancy

  1998cited by this paper
• Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.

  1997cited by this paper
• Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications.

  1997cited by this paper
• Membrane Type 1 Matrix Metalloproteinase Digests Interstitial Collagens and Other Extracellular Matrix Macromolecules*

  1997cited by this paper
• Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.

  1997cited by this paper
• Expression of Three Membrane-type Matrix Metalloproteinases (MT-MMPs) in Rat Vascular Smooth Muscle Cells and Characterization of MT3-MMPs with and without Transmembrane Domain*

  1997cited by this paper
• Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin.

  1997cited by this paper
• Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis.

  1996cited by this paper
• Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response.

  1996cited by this paper
• The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic Activation

  1996cited by this paper
• Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3

  1996cited by this paper
• Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic.

  1996cited by this paper
• Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma.

  1996cited by this paper
• Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

  1996cited by this paper
• MT-MMP expression and localisation in human lung and breast cancers

  1996cited by this paper
• Matrix metalloproteinases and the development of cancer.

  1996cited by this paper
• Transmembrane-deletion Mutants of the Membrane-type Matrix Metalloproteinase-1 Process Progelatinase A and Express Intrinsic Matrix-degrading Activity (*)

  1996cited by this paper
• Identification of the Second Membrane-type Matrix Metalloproteinase (MT-MMP-2) Gene from a Human Placenta cDNA Library

  1995cited by this paper
• Characterization of monoclonal antibodies against stromelysin‐3 and their use to evaluate stromelysin‐3 levels in breast carcinoma by semi‐quantitative immunohistochemistry

  1995cited by this paper
• Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas.

  1995cited by this paper
• The C-terminal Region of Membrane Type Matrix Metalloproteinase Is a Functional Transmembrane Domain Required for Pro-gelatinase A Activation (*)

  1995cited by this paper
• Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase

  1995cited by this paper
• cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment.

  1995cited by this paper
• Production and characterization of monoclonal antibodies recognising defined regions of the human oestrogen receptor.

  1993cited by this paper
• Tumor cell surface-associated binding site for the M(r) 72,000 type IV collagenase.

  1992cited by this paper

• Prognostic Role of Matrix Metalloproteinases in Cervical Cancer: A Meta-Analysis

  2021cites this paper
• Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance

  2021cites this paper
• The role of MMP-14 in ovarian cancer: a systematic review

  2021cites this paper
• Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis

  2020cites this paper
• Quantitative expression of MMPs 2, 9, 14, and collagen IV in LCIS and paired normal breast tissue

  2019cites this paper
• Fibroblasts in the Tumor Microenvironment: Shield or Spear?

  2018cites this paper
• Neurokinin-1 receptor mediated breast cancer cell migration by increased expression of MMP-2 and MMP-14.

  2016cites this paper
• Ο ρόλος του νοσηλευτή στην εκπαίδευση και ψυχολογική υποστήριξηασθενών με νεφρική ανεπάρκεια

  2015cites this paper
• The source of matrix-degrading enzymes in human cancer: Problems of research reproducibility and possible solutions

  2015cites this paper
• Involvement of the dopaminergic system in the consolidation of fear conditioning in hippocampal CA3 subregion.

  2015cites this paper
• Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14

  2014cites this paper
• Clinical Relevance of MMP and TIMP Measurements in Cancer Tissue

  2012cites this paper
• Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis

  2009cites this paper
• Role of Tumor Stromal Interactions and Proteases in Oral Cancer Metastasis

  2009cites this paper
• Membrane type 1 matrix metalloproteinase-mediated stromal syndecan-1 shedding stimulates breast carcinoma cell proliferation.

  2008cites this paper
• Experimental Study on Transarterial Administration of GRGDSP Combined with Transarterial Chemoembolization in Rats with Hepatic Carcinoma

  2008cites this paper
• Dimerization of endogenous MT1-MMP is a regulatory step in the activation of the 72-kDa gelatinase MMP-2 on fibroblasts and fibrosarcoma cells

  2008cites this paper
• The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA

  2008cites this paper
• The interaction of IQGAP 1 with the exocyst complex is required for tumor cell invasion downstream of Cdc 42 and RhoA

  2008cites this paper
• The clinicopathological and prognostic significance of membrane type 1 matrix metalloproteinase (MT1‐MMP) and MMP‐9 according to their localization in invasive breast carcinoma

  2007cites this paper
• Relationships between early inflammatory response to bleomycin and sensitivity to lung fibrosis: a role for dipeptidyl-peptidase I and tissue inhibitor of metalloproteinase-3?

  2007cites this paper
• Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells.

  2006cites this paper
• MT 1-MMP hemopexin domain exchange with MT 4-MMP blocks enzyme maturation and trafficking to the plasma membrane in MCF 7 cells

  2006cites this paper
• Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma

  2006cites this paper
• Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer.

  2006cites this paper
• MT1-MMP hemopexin domain exchange with MT4-MMP blocks enzyme maturation and trafficking to the plasma membrane in MCF7 cells.

  2006cites this paper
• The expression and regulation of membranetype matrix metalloproteinases (MT-MMPS) in prostate cancer

  2005cites this paper
• Extracellular protease mRNAs are predominantly expressed in the stromal areas of microdissected mouse breast carcinomas.

  2005cites this paper
• Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression.

  2005cites this paper
• TIMP-2 is released as an intact molecule following binding to MT1-MMP on the cell surface.

  2004cites this paper
• The metalloproteinase inhibitor TIMP-2 is down-regulated by androgens in LNCaP prostate carcinoma cells

  2004cites this paper
• Red Wine Polyphenolic Compounds Strongly Inhibit Pro-Matrix Metalloproteinase-2 Expression and Its Activation in Response to Thrombin via Direct Inhibition of Membrane Type 1–Matrix Metalloproteinase in Vascular Smooth Muscle Cells

  2004cites this paper
• Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice.

  2004cites this paper
• Restricted expression of membrane type 1‐matrix metalloproteinase by myofibroblasts adjacent to human breast cancer cells

  2003cites this paper
• Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion.

  2003cites this paper
• Stromal cell involvement in cancer.

  2003cites this paper
• Membrane type-matrix metalloproteinases (MT-MMP).

  2003cites this paper
• Proteases and Their Inhibitors in Cancer Metastasis

  2002cites this paper
• Role of Myofibroblasts at the Invasion Front

  2002cites this paper
• Expression of proteinases and inhibitors in human breast cancer progression and survival

  2002cites this paper
• Tumor-associated fibroblasts (part I): Active stromal participants in tumor development and progression?

  2002cites this paper
• Matrix metalloproteinases in neoplasm-induced extracellular matrix remodeling in breast carcinomas.

  2001cites this paper
• High serum concentrations of relaxin correlate with dissemination of breast cancer

  2001cites this paper
• Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions.

  2001cites this paper
• Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases.

  2000cites this paper
• Membrane‐type matrix metalloproteinases

  1999cites this paper